Pulmonary Hypertension Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014560537
Market Monitor Global
Oct-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Pulmonary Hypertension Drug in global, including the following market information:
Global Pulmonary Hypertension Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pulmonary Hypertension Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Pulmonary Hypertension Drug companies in 2020 (%)
The global Pulmonary Hypertension Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Hypertension Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Hypertension Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pulmonary Hypertension Drug Market Segment Percentages, By Type, 2020 (%)
IK-3001
Sildenafil Citrate IMD
IK-7002
Riociguat
SAR-407899
Others

Global Pulmonary Hypertension Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pulmonary Hypertension Drug Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others

Global Pulmonary Hypertension Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pulmonary Hypertension Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Hypertension Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pulmonary Hypertension Drug revenues share in global market, 2020 (%)
Key companies Pulmonary Hypertension Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Pulmonary Hypertension Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Vectura Group plc
Bayer AG
Ikaria Inc.
Proreo Pharma AG
Vicore Pharma AB
Biolab Sanus Farmaceutica Ltda.
Hanmi Pharmaceuticals, Co. Ltd.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pulmonary Hypertension Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Hypertension Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Hypertension Drug Overall Market Size
2.1 Global Pulmonary Hypertension Drug Market Size: 2021 VS 2027
2.2 Global Pulmonary Hypertension Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pulmonary Hypertension Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pulmonary Hypertension Drug Players in Global Market
3.2 Top Global Pulmonary Hypertension Drug Companies Ranked by Revenue
3.3 Global Pulmonary Hypertension Drug Revenue by Companies
3.4 Global Pulmonary Hypertension Drug Sales by Companies
3.5 Global Pulmonary Hypertension Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pulmonary Hypertension Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pulmonary Hypertension Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Hypertension Drug Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Hypertension Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Hypertension Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Hypertension Drug Market Size Markets, 2021 & 2027
4.1.2 IK-3001
4.1.3 Sildenafil Citrate IMD
4.1.4 IK-7002
4.1.5 Riociguat
4.1.6 SAR-407899
4.1.7 Others
4.2 By Type - Global Pulmonary Hypertension Drug Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Hypertension Drug Revenue, 2016-2021
4.2.2 By Type - Global Pulmonary Hypertension Drug Revenue, 2022-2027
4.2.3 By Type - Global Pulmonary Hypertension Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Pulmonary Hypertension Drug Sales & Forecasts
4.3.1 By Type - Global Pulmonary Hypertension Drug Sales, 2016-2021
4.3.2 By Type - Global Pulmonary Hypertension Drug Sales, 2022-2027
4.3.3 By Type - Global Pulmonary Hypertension Drug Sales Market Share, 2016-2027
4.4 By Type - Global Pulmonary Hypertension Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Hypertension Drug Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Pulmonary Hypertension Drug Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Hypertension Drug Revenue, 2016-2021
5.2.2 By Application - Global Pulmonary Hypertension Drug Revenue, 2022-2027
5.2.3 By Application - Global Pulmonary Hypertension Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Pulmonary Hypertension Drug Sales & Forecasts
5.3.1 By Application - Global Pulmonary Hypertension Drug Sales, 2016-2021
5.3.2 By Application - Global Pulmonary Hypertension Drug Sales, 2022-2027
5.3.3 By Application - Global Pulmonary Hypertension Drug Sales Market Share, 2016-2027
5.4 By Application - Global Pulmonary Hypertension Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pulmonary Hypertension Drug Market Size, 2021 & 2027
6.2 By Region - Global Pulmonary Hypertension Drug Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Hypertension Drug Revenue, 2016-2021
6.2.2 By Region - Global Pulmonary Hypertension Drug Revenue, 2022-2027
6.2.3 By Region - Global Pulmonary Hypertension Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Pulmonary Hypertension Drug Sales & Forecasts
6.3.1 By Region - Global Pulmonary Hypertension Drug Sales, 2016-2021
6.3.2 By Region - Global Pulmonary Hypertension Drug Sales, 2022-2027
6.3.3 By Region - Global Pulmonary Hypertension Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pulmonary Hypertension Drug Revenue, 2016-2027
6.4.2 By Country - North America Pulmonary Hypertension Drug Sales, 2016-2027
6.4.3 US Pulmonary Hypertension Drug Market Size, 2016-2027
6.4.4 Canada Pulmonary Hypertension Drug Market Size, 2016-2027
6.4.5 Mexico Pulmonary Hypertension Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pulmonary Hypertension Drug Revenue, 2016-2027
6.5.2 By Country - Europe Pulmonary Hypertension Drug Sales, 2016-2027
6.5.3 Germany Pulmonary Hypertension Drug Market Size, 2016-2027
6.5.4 France Pulmonary Hypertension Drug Market Size, 2016-2027
6.5.5 U.K. Pulmonary Hypertension Drug Market Size, 2016-2027
6.5.6 Italy Pulmonary Hypertension Drug Market Size, 2016-2027
6.5.7 Russia Pulmonary Hypertension Drug Market Size, 2016-2027
6.5.8 Nordic Countries Pulmonary Hypertension Drug Market Size, 2016-2027
6.5.9 Benelux Pulmonary Hypertension Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pulmonary Hypertension Drug Revenue, 2016-2027
6.6.2 By Region - Asia Pulmonary Hypertension Drug Sales, 2016-2027
6.6.3 China Pulmonary Hypertension Drug Market Size, 2016-2027
6.6.4 Japan Pulmonary Hypertension Drug Market Size, 2016-2027
6.6.5 South Korea Pulmonary Hypertension Drug Market Size, 2016-2027
6.6.6 Southeast Asia Pulmonary Hypertension Drug Market Size, 2016-2027
6.6.7 India Pulmonary Hypertension Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pulmonary Hypertension Drug Revenue, 2016-2027
6.7.2 By Country - South America Pulmonary Hypertension Drug Sales, 2016-2027
6.7.3 Brazil Pulmonary Hypertension Drug Market Size, 2016-2027
6.7.4 Argentina Pulmonary Hypertension Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Hypertension Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pulmonary Hypertension Drug Sales, 2016-2027
6.8.3 Turkey Pulmonary Hypertension Drug Market Size, 2016-2027
6.8.4 Israel Pulmonary Hypertension Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Pulmonary Hypertension Drug Market Size, 2016-2027
6.8.6 UAE Pulmonary Hypertension Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Pulmonary Hypertension Drug Major Product Offerings
7.1.4 Sanofi Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.1.5 Sanofi Key News
7.2 Vectura Group plc
7.2.1 Vectura Group plc Corporate Summary
7.2.2 Vectura Group plc Business Overview
7.2.3 Vectura Group plc Pulmonary Hypertension Drug Major Product Offerings
7.2.4 Vectura Group plc Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.2.5 Vectura Group plc Key News
7.3 Bayer AG
7.3.1 Bayer AG Corporate Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Pulmonary Hypertension Drug Major Product Offerings
7.3.4 Bayer AG Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.3.5 Bayer AG Key News
7.4 Ikaria Inc.
7.4.1 Ikaria Inc. Corporate Summary
7.4.2 Ikaria Inc. Business Overview
7.4.3 Ikaria Inc. Pulmonary Hypertension Drug Major Product Offerings
7.4.4 Ikaria Inc. Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.4.5 Ikaria Inc. Key News
7.5 Proreo Pharma AG
7.5.1 Proreo Pharma AG Corporate Summary
7.5.2 Proreo Pharma AG Business Overview
7.5.3 Proreo Pharma AG Pulmonary Hypertension Drug Major Product Offerings
7.5.4 Proreo Pharma AG Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.5.5 Proreo Pharma AG Key News
7.6 Vicore Pharma AB
7.6.1 Vicore Pharma AB Corporate Summary
7.6.2 Vicore Pharma AB Business Overview
7.6.3 Vicore Pharma AB Pulmonary Hypertension Drug Major Product Offerings
7.6.4 Vicore Pharma AB Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.6.5 Vicore Pharma AB Key News
7.7 Biolab Sanus Farmaceutica Ltda.
7.7.1 Biolab Sanus Farmaceutica Ltda. Corporate Summary
7.7.2 Biolab Sanus Farmaceutica Ltda. Business Overview
7.7.3 Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Major Product Offerings
7.4.4 Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.7.5 Biolab Sanus Farmaceutica Ltda. Key News
7.8 Hanmi Pharmaceuticals, Co. Ltd.
7.8.1 Hanmi Pharmaceuticals, Co. Ltd. Corporate Summary
7.8.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
7.8.3 Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Major Product Offerings
7.8.4 Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Sales and Revenue in Global (2016-2021)
7.8.5 Hanmi Pharmaceuticals, Co. Ltd. Key News
8 Global Pulmonary Hypertension Drug Production Capacity, Analysis
8.1 Global Pulmonary Hypertension Drug Production Capacity, 2016-2027
8.2 Pulmonary Hypertension Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Hypertension Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Hypertension Drug Supply Chain Analysis
10.1 Pulmonary Hypertension Drug Industry Value Chain
10.2 Pulmonary Hypertension Drug Upstream Market
10.3 Pulmonary Hypertension Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Hypertension Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pulmonary Hypertension Drug in Global Market
Table 2. Top Pulmonary Hypertension Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pulmonary Hypertension Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pulmonary Hypertension Drug Revenue Share by Companies, 2016-2021
Table 5. Global Pulmonary Hypertension Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Pulmonary Hypertension Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pulmonary Hypertension Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Pulmonary Hypertension Drug Product Type
Table 9. List of Global Tier 1 Pulmonary Hypertension Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Hypertension Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Sanofi
Vectura Group plc
Bayer AG
Ikaria Inc.
Proreo Pharma AG
Vicore Pharma AB
Biolab Sanus Farmaceutica Ltda.
Hanmi Pharmaceuticals, Co. Ltd.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE